English press releases

Reltio Expands Global Footprint, Opens New Office in Lisbon, Portugal

Portugal facility will serve as technology hub in Europe, focused on developing innovation with cloud, big data, and machine learning technology REDWOOD SHORES, Calif.–(BUSINESS WIRE)–...

Ant Group Grows Partnership with STB to Drive Tourism Demand from Asia to Singapore

The latest phase of the partnership includes the “SingapoReimagine with Alipay+” joint marketing campaign. Three new mobile wallets are accepted in Singapore through Alipay+, bringing...

H.I.G. Realty Hires Alessio Lucentini as Real Estate Head of Asset Management in Europe

LONDON–(BUSINESS WIRE)– H.I.G. Capital, LLC (“H.I.G.”), a leading global alternative investment firm with $52 billion of equity capital under management, announced that it has hired...

Merck Highlights New Data for Evobrutinib, First BTKi to Demonstrate Sustained Clinical Benefit for People with RMS through Three and a Half Years of Treatment

Phase II clinical trial data of evobrutinib demonstrated low disease activity and stable EDSS, with NfL levels, a marker of neuronal injury, remaining low in...

Merck Showcases Depth of MS Portfolio at ECTRIMS Supporting Commitment to Advancing MS Care

Company’s scientific leadership will be highlighted in 39 abstracts presented across its multiple sclerosis (MS) portfolio Data on investigational BTK inhibitor evobrutinib demonstrate long-term disease...

Alipay+ featured at SHEIN’s offline popup store debut in the Philippines

GCash users making online payment through Alipay+ inside SHEIN’s first-ever popup store were enjoying discounts and winning an exquisite gift from Alipay+ as the payment...

IFF and Florida Polytechnic University Celebrate Beginning of Construction on State-of-the-Art Global Citrus Innovation Center

Public-private partnership to advance citrus research, development of breakthrough solutions for food, beverage and fragrance industries LAKELAND, Fla.–(BUSINESS WIRE)– Today in a ceremonial presentation, IFF...

Ipsen Statement on Updated Timeline for Palovarotene FDA Advisory Committee Meeting

PARIS–(BUSINESS WIRE)– Regulatory News: Disclaimer: Intended for international media and investor audiences only Ipsen (Euronext: IPN; ADR: IPSEY) reports that the U.S. Food and Drug...

Micreos’ Alternative to Antibiotics Secures Next €25 Million

THE HAGUE, The Netherlands–(BUSINESS WIRE)– Dutch/Swiss biotech company Micreos announced today it has secured its next funding round of €25 million in growth capital and...

Adrestia appoints Head of Chemistry and initiates multi-target partnership with Proteros to discover first-in-class drugs for intractable genetic diseases

Drug discovery leader Dr James Osborne brings strong track record of delivering drug candidates for oncology and CNS disorders Proteros selected for its cutting-edge structure-based...

Logitech Announces Q2 FY 2023 Results

Company Reaffirms Fiscal Year 2023 Outlook LAUSANNE, Switzerland & NEWARK, Calif.–(BUSINESS WIRE)– SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech...

IFF to Release Third Quarter 2022 Results November 7

NEW YORK–(BUSINESS WIRE)– IFF (NYSE:IFF) today announced that it will release its third quarter 2022 earnings results following the market close on Monday, Nov. 7,...

Lodbrok and Water Street Request REC’s Board to Summon an EGM to Elect New Director

LONDON–(BUSINESS WIRE)– Lodbrok Capital LLP recently sent the letter below to the Board of REC Silicon ASA, requesting they summon an EGM for the purpose...

Alibaba Group Kicks Off 2022 11.11 Global Shopping Festival

Cultivating loyal customers for brands Delivering an innovative and green event HANGZHOU, China–(BUSINESS WIRE)– Alibaba Group Holding Limited (NYSE: BABA; HKEX: 9988) today officially kicked...

ViiV Healthcare Presents Positive Data Showing Vocabria (cabotegravir) and Rekambys (rilpivirine) Can Be Successfully Implemented Across a Range of European Healthcare Settings

Healthcare teams from diverse European HIV clinics reported that the implementation of the complete long-acting regimen was acceptable, appropriate, and feasible, with the majority of...